• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Casper Sleep Inc. Announces Stockholder Approval of Merger Agreement

    1/19/22 4:09:00 PM ET
    $CSPR
    Diversified Commercial Services
    Miscellaneous
    Get the next $CSPR alert in real time by email

    Casper Sleep Inc. (NYSE:CSPR) ("Casper" or the "Company") announced that its stockholders voted today to adopt the Agreement and Plan of Merger (the "Merger Agreement"), whereby Casper will be acquired by certain subsidiaries of Durational Consumer SPV IV, LP (the "Durational Vehicle"), an investment vehicle managed by Durational Capital Management, LP. According to the preliminary results announced at Casper's Special Meeting of Stockholders, approximately 69.5% of the vote represented by Casper's outstanding stock were voted in favor of the Merger Agreement. The final voting results of the Special Meeting, as tabulated by an independent inspector of elections, will be filed as part of Form 8-K with the U.S. Securities and Exchange Commission.

    Subject to the satisfaction of certain other closing conditions, the transaction is expected to close during the week of January 24, 2022. Upon closing the transaction, Casper will operate as a privately-held company and will remain based in New York.

    About Casper

    Casper believes everyone should sleep better. The Sleep Company has a full portfolio of obsessively engineered sleep products—including mattresses, pillows, bedding, and furniture designed in-house by the Company's award-winning R&D team at Casper Labs. In addition to its e-commerce business, Casper owns and operates Sleep Shops across North America and its products are available at a growing list of retailers.

    About Durational Capital Management, LP

    Based in New York, Durational Capital Management, LP is an investment firm that invests in high quality consumer companies. Durational approaches its investments with a strategic mindset and focuses on driving long-term value creation through partnership with top tier management teams and actively supporting management to drive operational improvements. The firm was founded in 2017, and its investment professionals have extensive experience investing in the consumer sector. For more information, visit: www.durational.com.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the impact of the COVID-19 pandemic and the related effect on our employees, customers and business operations; our business strategy and plans; the future growth of our business; objectives of management for future operations and creating long-term value; the management transition and anticipated benefits thereof; and the proposed transaction with Durational Capital Management, LP and anticipated benefits thereof. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: including the completion of the proposed transaction on anticipated terms and timing, including obtaining stockholder and regulatory approvals, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the Company's business and other conditions to the completion of the transaction; conditions to the closing of the transaction may not be satisfied; the transaction may involve unexpected costs, liabilities or delays; the outcome of any legal proceedings related to the transaction; the failure by Durational Capital Management, LP to obtain the necessary debt financing arrangements set forth in the commitment letters received in connection with the transaction; potential litigation relating to the proposed transaction; the risk that disruptions from the proposed transaction will harm the Company's business, including current plans and operations; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction; and restrictions during the pendency of the proposed transaction that may impact the Company's ability to pursue certain business opportunities or strategic transactions; we will need additional financing to execute our business plan, to fund our operations and to continue as a going concern; the COVID-19 pandemic could adversely impact our business, financial condition and results of operations; our ability to compete successfully in the highly competitive industries in which we operate; our ability to maintain and enhance our brand; the success of our retail store and retail partnerships expansion plans; our ability to successfully implement our growth strategies related to launching new products; the effectiveness and efficiency of our marketing programs; our ability to manage our current operations and to manage future growth effectively; our past results may not be indicative of our future operating performance; our ability to manage our supply chain commensurate with demand and successfully and timely deliver merchandise to our retail partners and customers; the duration and impact of current supply chain constraints and inflationary pressures our business, financial condition and results of operations; our ability to attract new customers or retain existing customers; the growth of the market for sleep as a retail category and our ability to become a leader or maintain our leadership in the category; the impact of social media and influencers on our reputation; our ability to protect and maintain our intellectual property; our exclusive reliance on third-party contract manufacturers whose efforts we are unable to fully control; our ability to effectively implement strategic initiatives; our ability to transfer our supply chain and other business processes to a global scale; risks relating to fluctuations in the cost and availability of raw materials and fuel; risks relating to our international operations and expansion; we are dependent on our retail partners; general economic and business conditions; we or our service providers could be subject to system failures or interruptions, cyber-based attacks and security breaches or other incidents; risks relating to changing legal and regulatory requirements, and any failure to comply with applicable laws and regulations; we may be subject to product liability claims and other litigation; we may experience fluctuations in our quarterly operating results; we have and expect to continue to incur significant losses; risks relating to our indebtedness; our need for additional funding, which may not be available; risks relating to taxes; our ability to attract and retain qualified personnel; future sales by us our stockholders may cause the market price of our stock to decline; and risks and additional costs relating to our status as a public company. These and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 and our other filings with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220119006060/en/

    Get the next $CSPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CSPR

    DatePrice TargetRatingAnalyst
    11/16/2021Buy → Neutral
    Guggenheim
    11/16/2021$9.50 → $6.90Buy → Neutral
    Citigroup
    11/10/2021$8.00 → $3.50Overweight → Neutral
    Piper Sandler
    10/25/2021Outperform → Neutral
    Wedbush
    8/11/2021$14.00 → $12.00Buy
    Roth Capital
    7/14/2021$7.00Sell
    Goldman Sachs
    More analyst ratings

    $CSPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BeautyHealth Names Michael Monahan Chief Financial Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announces Michael Monahan has been named Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230809857384/en/Michael Monahan, BeautyHealth (Photo: Business Wire) "Michael joins BeautyHealth as we bring to life our vision of a multi-brand ecosystem company, with a significant and untapped runway ahead. He is a highly regarded CFO with a strong blend of financial exper

      8/9/23 7:25:00 AM ET
      $SKIN
      $CSPR
      Medical/Dental Instruments
      Health Care
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. Announces Stockholder Approval of Merger Agreement

      Casper Sleep Inc. (NYSE:CSPR) ("Casper" or the "Company") announced that its stockholders voted today to adopt the Agreement and Plan of Merger (the "Merger Agreement"), whereby Casper will be acquired by certain subsidiaries of Durational Consumer SPV IV, LP (the "Durational Vehicle"), an investment vehicle managed by Durational Capital Management, LP. According to the preliminary results announced at Casper's Special Meeting of Stockholders, approximately 69.5% of the vote represented by Casper's outstanding stock were voted in favor of the Merger Agreement. The final voting results of the Special Meeting, as tabulated by an independent inspector of elections, will be filed as part of For

      1/19/22 4:09:00 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Accrue Savings Raises $25M Series A led by Tiger Global

      Aglaé Ventures, Maple VC, UPS CEO Carol Tomé and Fanatics CEO Michael Rubin join Twelve Below, Box Group, and others in the burgeoning payments start-up that enables retailers to power customers' savings goals Accrue Savings, the merchant-embedded shopping experience that rewards consumers for saving, today announced it raised $25 million in a Series A funding round led by Tiger Global, with participation from Aglaé Ventures, the tech investment firm backed by Groupe Arnault, Maple VC, and notable leaders such as UPS CEO Carol Tomé and Fanatics CEO Michael Rubin. Returning investors include Twelve Below, Box Group, Red Sea Ventures, Ground Up Ventures, Good Friends, Silas Capital Ventures,

      1/13/22 8:00:00 AM ET
      $CSPR
      $SDC
      Diversified Commercial Services
      Miscellaneous
      Medical/Dental Instruments
      Health Care

    $CSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by New Enterprise Associates 14, L.P.

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 6:02:41 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form 4: Florence Anthony A. Jr. returned $43,165,682 worth of shares to the company (6,255,896 units at $6.90), closing all direct ownership in the company (for tax liability)

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 5:58:02 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form 4: Monahan Michael P. returned $1,296,662 worth of shares to the company (187,922 units at $6.90), closing all direct ownership in the company (for withholding tax)

      4 - Casper Sleep Inc. (0001598674) (Issuer)

      1/26/22 5:03:09 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Casper Sleep Inc. (Amendment)

      SC 13G/A - Casper Sleep Inc. (0001598674) (Subject)

      1/26/22 5:00:12 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form SC 13G filed by Casper Sleep Inc.

      SC 13G - Casper Sleep Inc. (0001598674) (Subject)

      1/21/22 4:48:25 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form SC 13D/A filed by Casper Sleep Inc. (Amendment)

      SC 13D/A - Casper Sleep Inc. (0001598674) (Subject)

      11/22/21 5:12:14 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Financials

    Live finance-specific insights

    See more
    • Casper Sleep Inc. to Be Acquired by Durational Capital Management

      $6.90 Per Share Purchase Price Delivers Substantial 94% Premium Casper Sleep Inc. (NYSE:CSPR) ("Casper" or "the Company") announced today that it entered into a definitive agreement to be acquired by Durational Capital Management LP ("Durational"). Under the terms of the agreement, Casper common stockholders will receive cash consideration of $6.90 per share, representing a 94% premium to the closing share price on November 12, 2021, the last trading day prior to this announcement and a premium of approximately 80% to the 30-day volume weighted average price ending November 12, 2021. Transaction Details Casper's Board of Directors has unanimously approved the transaction and recommends t

      11/15/21 8:15:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15

      Casper Sleep Inc. (NYSE:CSPR), the award-winning sleep company, announced today that it will release its third quarter 2021 financial results after the market closes on Monday, November 15, 2021. Following the release, the Company will host a live conference call and audio webcast at 5:00 p.m. ET on November 15, 2021 to review these results and other business updates. To access the conference call, interested parties may dial 866-319-1799 (for domestic callers) or 825-312-2362 (for international callers). Please call at least five minutes in advance of the start of the call to ensure that you are connected prior to the call. Interested parties may also access a live audio webcast of the ca

      11/3/21 8:30:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10

      NEW YORK--(BUSINESS WIRE)--Casper Sleep Inc. (NYSE: CSPR), the award-winning sleep company, announced today that it will release its second quarter 2021 financial results before the market opens on Tuesday, August 10, 2021. Following the release, the Company will host a live conference call and audio webcast at 8:00 a.m. ET on August 10, 2021 to review these results and other business updates. To access the conference call, interested parties may dial 866-319-1799 (for domestic callers) or 825-312-2362 (for international callers). Please call at least five minutes in advance of the start of the call to ensure that you are connected prior to the call. Interested parties may also acc

      7/23/21 11:15:00 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    SEC Filings

    See more
    • SEC Form 15-12B filed by Casper Sleep Inc.

      15-12B - Casper Sleep Inc. (0001598674) (Filer)

      2/4/22 6:02:06 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep Inc. filed SEC Form 8-K: Leadership Update

      8-K - Casper Sleep Inc. (0001598674) (Filer)

      1/28/22 5:00:34 PM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • SEC Form EFFECT filed by Casper Sleep Inc.

      EFFECT - Casper Sleep Inc. (0001598674) (Filer)

      1/27/22 12:15:21 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous

    $CSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Casper Sleep downgraded by Guggenheim

      Guggenheim downgraded Casper Sleep from Buy to Neutral

      11/16/21 7:11:36 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep downgraded by Citigroup with a new price target

      Citigroup downgraded Casper Sleep from Buy to Neutral and set a new price target of $6.90 from $9.50 previously

      11/16/21 6:41:27 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous
    • Casper Sleep downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Casper Sleep from Overweight to Neutral and set a new price target of $3.50 from $8.00 previously

      11/10/21 5:20:36 AM ET
      $CSPR
      Diversified Commercial Services
      Miscellaneous